| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |